The Impact of Obesity on Durable Left Ventricular Assist Device Implantation: A Systematic Review and Meta‐Analysis

Obesity does not confer excess short-term or long-term mortality after durable LVAD implantation but is associated with substantially higher risks of infection, pump thrombosis, and right heart failure. These findings suggest that obesity alone should not preclude LVAD candidacy, while underscoring the need to recognize and manage the increased morbidity burden in this population and to further investigate outcomes in contemporary, device-specific cohorts.